JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.97B |
| 2 |
Vanguard Total Bond Market
BND
|
+$1.96B |
| 3 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.61B |
| 4 |
UnitedHealth
UNH
|
+$1.1B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.25B |
| 2 |
Centene
CNC
|
+$827M |
| 3 |
Amazon
AMZN
|
+$791M |
| 4 |
Texas Instruments
TXN
|
+$716M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$569M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.62% |
| 2 | Healthcare | 12.48% |
| 3 | Financials | 10.51% |
| 4 | Consumer Discretionary | 8.11% |
| 5 | Industrials | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
PUT
FirstEnergy
FE
$27.3B
| $4.89M | ﹤0.01% |
132,300
| – | – |
|
2627
ZTO Express
ZTO
$17.4B
| $4.89M | ﹤0.01% |
203,641
-200,196
| -50% | -$5.22M |
|
2628
CALL
Air Products & Chemicals
APD
$68.3B
| $4.89M | ﹤0.01% |
21,000
| – | – |
|
2629
Marathon Digital Holdings
MARA
$3.49B
| $4.89M | ﹤0.01% |
456,341
-74,151
| -14% | -$878K |
|
2630
CALL
Cencora
COR
$59.3B
| $4.88M | ﹤0.01% |
+36,100
| New | +$5.18M |
|
2631
Teva Pharmaceuticals
TEVA
$42.6B
| $4.88M | ﹤0.01% |
604,650
+66,669
| +12% | +$590K |
|
2632
CALL
SoFi Technologies
SOFI
$23.8B
| $4.88M | ﹤0.01% |
999,600
| – | – |
|
|
CSII
2633
DELISTED
Cardiovascular Systems, Inc.
CSII
| $4.88M | ﹤0.01% |
351,883
-13,779
| -4% | -$205K |
|
|
NAAC
2634
DELISTED
North Atlantic Acquisition Corporation Class A Ordinary Share
NAAC
| $4.87M | ﹤0.01% |
+490,000
| New | +$4.85M |
|
2635
Viasat
VSAT
$11.2B
| $4.87M | ﹤0.01% |
161,148
+43,182
| +37% | +$1.45M |
|
2636
Global Net Lease
GNL
$1.88B
| $4.87M | ﹤0.01% |
457,177
+51,581
| +13% | +$718K |
|
2637
CALL
Southern Company
SO
$107B
| $4.86M | ﹤0.01% |
71,500
| – | – |
|
|
HES
2638
PUT
DELISTED
Hess
HES
| $4.86M | ﹤0.01% |
44,600
+34,700
| +351% | +$3.85M |
|
2639
CALL
Baidu
BIDU
$35.1B
| $4.85M | ﹤0.01% |
41,300
+7,200
| +21% | +$983K |
|
|
RXDX
2640
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $4.84M | ﹤0.01% |
82,109
-291
| -0.4% | -$13.3K |
|
2641
Privia Health
PRVA
$2.81B
| $4.84M | ﹤0.01% |
142,139
-51,906
| -27% | -$1.92M |
|
2642
PUT
International Paper
IP
$21.5B
| $4.82M | ﹤0.01% |
152,140
+2,400
| +2% | +$98.1K |
|
|
TRTN
2643
DELISTED
Triton International Limited
TRTN
| $4.82M | ﹤0.01% |
88,107
+1,964
| +2% | +$118K |
|
2644
HNI Corp
HNI
$3.55B
| $4.82M | ﹤0.01% |
181,790
+6,921
| +4% | +$230K |
|
|
THS
2645
DELISTED
Treehouse Foods
THS
| $4.82M | ﹤0.01% |
113,613
+15,438
| +16% | +$692K |
|
2646
Usana Health Sciences
USNA
$251M
| $4.82M | ﹤0.01% |
85,967
+1,987
| +2% | +$131K |
|
2647
Corporacion America
CAAP
$6.43B
| $4.81M | ﹤0.01% |
724,859
+8,416
| +1% | +$50.2K |
|
2648
CALL
UBS Group
UBS
$176B
| $4.81M | ﹤0.01% |
331,600
-285,900
| -46% | -$4.58M |
|
|
KLRS
2649
Kalaris Therapeutics
KLRS
$97.8M
| $4.81M | ﹤0.01% |
26,484
-7,247
| -21% | -$1.13M |
|
2650
Vanguard Long-Term Bond ETF
BLV
$5.69B
| $4.8M | ﹤0.01% |
66,719
+62,608
| +1,523% | +$4.95M |
|
Similar funds
JP Morgan Chase's Q3 2022 Portfolio in Review
As of Q3 2022, JP Morgan Chase held 7,216 positions worth $696B, down 3% from $718B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q3 2022 filing shows 557 new, 2,573 increased, 2,584 reduced and 515 closed positions. Its largest new stake was Franklin FTSE Japan ETF: 3,003,780 shares worth $65.1M. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $1.25B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q3 2022 buy was Franklin FTSE Japan ETF: 3,003,780 shares worth $65.1M.
- JP Morgan Chase added most to Invesco QQQ Trust in Q3 2022, an estimated $1.97B increase.
- JP Morgan Chase's biggest Q3 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $1.25B.
- JP Morgan Chase fully exited CMC Materials, Inc. Common Stock in Q3 2022, selling an estimated $248M.
- JP Morgan Chase's ten largest holdings make up 17% of its $696B portfolio in Q3 2022.
- JP Morgan Chase opened 557 new positions and closed 515 in Q3 2022.
- JP Morgan Chase's portfolio value fell 3% quarter-over-quarter to $696B.
Based on JP Morgan Chase's 13F filing for Q3 2022, filed 14 Nov 2022.